(Total Views: 456)
Posted On: 07/15/2021 3:45:35 PM
Post# of 37
$RVVTF (interesting opinion) by Crusader on Yh0 - "The Company is in discussions with reputable international pharmaceutical companies seeking to obtain commercial rights to Bucillamine as a treatment for COVID-19 in various countries in Europe, India and Asia.
In light of these discussions, Revive is pursuing a commercialization plan that would leverage the clinical results from the U.S. Phase 3 study to allow for drug approvals globally."
In light of these discussions, Revive is pursuing a commercialization plan that would leverage the clinical results from the U.S. Phase 3 study to allow for drug approvals globally."
(0)
(0)
$MJ
